BioLineRx (BLRX) Exchange Rate Effect (2013 - 2026)
BioLineRx (BLRX) posted quarterly Exchange Rate Effect of $125000.0 for Q4 2025, down 22.84% year-over-year from $162000.0 in Q4 2024, and down 83.85% quarter-over-quarter from $774000.0 in Q3 2025.
Powered by 
Analysis
BioLineRx (BLRX) Exchange Rate Effect (2013 - 2026) Analysis & Trends
BioLineRx's Exchange Rate Effect history runs 13 years deep, the most recent figure standing at $125000.0 for Q4 2025.
- In Q4 2025, Exchange Rate Effect fell 22.84% year-over-year to $125000.0; the TTM figure through Dec 2025 stood at $549000.0 (up 2395.45% YoY), while the FY2025 annual figure was $549000.0, up 2395.45% from the prior year.
- Exchange Rate Effect for Q4 2025 stood at $125000.0, down from $774000.0 in the prior quarter.
- The five-year high for Exchange Rate Effect was $774000.0 in Q3 2025, with the low at -$1.1 million in Q3 2022.
- The 5-year median for Exchange Rate Effect is $500.0 (2022), against an average of -$2650.0.
- The sharpest annual moves came in 2022 and 2025: Exchange Rate Effect tumbled 1621.54% in 2022, then soared 855.56% in 2025.
- BioLineRx's Exchange Rate Effect stood at $244000.0 in 2021, then slumped by 120.49% to -$50000.0 in 2022, then soared by 484.0% to $192000.0 in 2023, then dropped by 15.62% to $162000.0 in 2024, then slipped by 22.84% to $125000.0 in 2025.
- Business Quant data shows BLRX's Exchange Rate Effect at $125000.0 in Q4 2025, $774000.0 in Q3 2025, and -$268000.0 in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.87 Bn | 131.01 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.57 Bn | 77.57 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.19 Bn | 53.05 Bn | 52.00 Mn | -2.00 Mn |
| 5 | Revolution Medicines | 44.07 Bn | 44.07 Bn | - | - |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn | 19.84 Mn |
| 7 | Alnylam Pharmaceuticals | 35.38 Bn | 32.07 Bn | 992.69 Mn | -2.45 Mn |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | - |
| 9 | Insmed | 27.41 Bn | 26.25 Bn | 358.27 Mn | -287,000.00 |
| 10 | BioLineRx | 6.46 Bn | 6.46 Bn | 235,000.00 | 132,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 132,000.00 |
| Mar 31, 2026 | 11,000.00 |
| Dec 31, 2025 | -973,000.00 |
| Sep 30, 2025 | 74,000.00 |
| Jun 30, 2025 | 432,000.00 |
| Mar 31, 2025 | -82,000.00 |
| Dec 31, 2024 | 118,000.00 |
| Sep 30, 2024 | 81,000.00 |
| Jun 30, 2024 | -272,000.00 |
| Mar 31, 2024 | 51,000.00 |
| Dec 31, 2023 | 640,000.00 |
| Sep 30, 2023 | -72,000.00 |
| Jun 30, 2023 | -246,000.00 |
| Mar 31, 2023 | -98,000.00 |
| Dec 31, 2022 | 1.16 Mn |
| Sep 30, 2022 | 5,000.00 |
| Jun 30, 2022 | -499,000.00 |
| Mar 31, 2022 | -63,000.00 |
| Dec 31, 2021 | 244,000.00 |
| Sep 30, 2021 | -9,000.00 |